An overview of current treatment methods for Budd–Chiari syndrome

Bibliography

• Janssen HL, Garcia-Pagan JC, Elias E, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38(3):364-71
   PubMedGoogle Scholar
• DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009;49(5):1729-64
   PubMed Web of Science ®Google Scholar
• Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998;27(2):488-96
   PubMedGoogle Scholar
• Valla DC. Hepatic venous outflow tract obstruction etiopathogenesis: asia versus the West. J Gastroenterol Hepatol 2004;19:S204-11
   Google Scholar
• Darwish MS, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151(3):167-75
   PubMedGoogle Scholar
• Shrestha SM, Okuda K, Uchida T, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996;11(2):170-9
   PubMedGoogle Scholar
• Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol 2008;14(2):278-85
   PubMedGoogle Scholar
• Horton JD, San Miguel FL, Membreno F, et al. Budd-Chiari syndrome: illustrated review of current management. Liver Int 2008;28(4):455-66
   PubMed Web of Science ®Google Scholar
• Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22(1):15-26
   PubMedGoogle Scholar
• Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31(3):587-91
   PubMed Web of Science ®Google Scholar
• Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96(7):2364-8
   PubMed Web of Science ®Google Scholar
• Primignani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44(6):1528-34
   PubMedGoogle Scholar
• Primignani M, Mannucci PM. The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 2008;28(3):293-301
   PubMedGoogle Scholar
• Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007;110(4):1092-7
   PubMed Web of Science ®Google Scholar
• Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008;111(10):4922-9
   PubMed Web of Science ®Google Scholar
• Seijo S, Plessier A, Hoekstra J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013;57(5):1962-8
   PubMedGoogle Scholar
• Qi X, Wu F, Ren W, et al. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost 2013;109(5):878-84
   PubMedGoogle Scholar
• Cheng D, Xu H, Lu ZJ, et al. Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: a single-center study. J Gastroenterol Hepatol 2013;28(6):1061-7
   PubMed Web of Science ®Google Scholar
• Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis 2008;28(3):259-69
   PubMedGoogle Scholar
• Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106(4):1042-7
   PubMedGoogle Scholar
• Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002;22(1):5-14
   PubMed Web of Science ®Google Scholar
• Darwish MS, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006;101(1):83-90
   PubMedGoogle Scholar
• Wanless IR. Benign liver tumors. Clin Liver Dis 2002;6(2):513-26
   PubMedGoogle Scholar
• Vilgrain V, Lewin M, Vons C, et al. Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 1999;210(2):443-50
   PubMedGoogle Scholar
• Flor N, Zuin M, Brovelli F, et al. Regenerative nodules in patients with chronic Budd-Chiari syndrome: a longitudinal study using multiphase contrast-enhanced multidetector CT. Eur J Radiol 2010;73(3):588-93
   PubMedGoogle Scholar
• Moucari R, Rautou PE, Cazals-Hatem D, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008;57(6):828-35
   PubMedGoogle Scholar
• Ren W, Qi X, Yang Z, et al. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol 2013;25(7):830-41
   PubMedGoogle Scholar
• Miller WJ, Federle MP, Straub WH, Davis PL. Budd-Chiari syndrome: imaging with pathologic correlation. Abdom Imaging 1993;18(4):329-35
   PubMedGoogle Scholar
• Riggio O, Marzano C, Papa A, et al. Small hepatic veins Budd-Chiari syndrome. J Thromb Thrombolysis 2013. [Epub ahead of print]
   Google Scholar
• Hernandez-Guerra M, Lopez E, Bellot P, et al. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology 2006;43(1):27-33
   PubMedGoogle Scholar
• Smalberg JH, Darwish MS, Braakman E, et al. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica 2006;91(12):1712-13
   PubMedGoogle Scholar
• Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006;130(7):2031-8
   PubMedGoogle Scholar
• Bittencourt PL, Couto CA, Ribeiro DD. Portal vein thrombosis and Budd-Chiari syndrome. Clin Liver Dis 2009;13(1):127-44
   PubMedGoogle Scholar
• Espinosa G, Font J, Garcia-Pagan JC, et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore) 2001;80(6):345-54
   PubMedGoogle Scholar
• Rautou PE, Douarin L, Denninger MH, et al. Bleeding in patients with Budd-Chiari syndrome. J Hepatol 2011;54(1):56-63
   PubMedGoogle Scholar
• Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44(5):1308-16
   PubMedGoogle Scholar
• Rautou PE, Angermayr B, Garcia-Pagan JC, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol 2009;51(1):47-54
   PubMedGoogle Scholar
• Valla D, Hadengue A, El Younsi M, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology 1997;25(4):814-19
   PubMedGoogle Scholar
• Fisher NC, McCafferty I, Dolapci M, et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999;44(4):568-74
   PubMedGoogle Scholar
• Han G, Qi X, Zhang W, et al. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 2013;266(2):657-67
   PubMedGoogle Scholar
• Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol 2003;9(11):2587-91
   PubMedGoogle Scholar
• Mitchell MC, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) 1982;61(4):199-218
   PubMed Web of Science ®Google Scholar
• Hemming AW, Langer B, Greig P, et al. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996;171(1):176-80
   PubMedGoogle Scholar
• Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30(1):84-9
   PubMedGoogle Scholar
• Langlet P, Valla D. Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome? Acta Gastroenterol Belg 2002;65(3):155-60
   PubMedGoogle Scholar
• Panis Y, Belghiti J, Valla D, et al. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 1994;115(3):276-81
   PubMedGoogle Scholar
• Bachet JB, Condat B, Hagege H, et al. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007;46(1):60-8
   PubMedGoogle Scholar
• Orloff MJ, Isenberg JI, Wheeler HO, et al. Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression. J Gastrointest Surg 2012;16(2):286-300
   PubMedGoogle Scholar
• Montano-Loza AJ, Tandon P, Kneteman N, et al. Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival. Aliment Pharmacol Ther 2009;30(10):1060-9
   PubMedGoogle Scholar
• Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol 2013;48(7):771-84
   PubMed Web of Science ®Google Scholar
• Perarnau JM, Bacq Y. Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy. Semin Liver Dis 2008;28(3):315-27
   PubMedGoogle Scholar
• Garcia-Pagan JC, Heydtmann M, Raffa S, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135(3):808-15
   PubMed Web of Science ®Google Scholar
• Hernandez-Guerra M, Turnes J, Rubinstein P, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40(5):1197-202
   PubMedGoogle Scholar
• Perello A, Garcia-Pagan JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002;35(1):132-9
   PubMedGoogle Scholar
• Shaked A, Goldstein RM, Klintmalm GB, et al. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992;174(6):453-9
   PubMedGoogle Scholar
• Turnes J, Garcia-Pagan JC, Gonzalez-Abraldes J, et al. Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients. Liver Transpl 2001;7(7):649-51
   PubMedGoogle Scholar
• Segev DL, Nguyen GC, Locke JE, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl 2007;13(9):1285-94
   PubMedGoogle Scholar
• Yamada T, Tanaka K, Ogura Y, et al. Surgical techniques and long-term outcomes of living donor liver transplantation for Budd-Chiari syndrome. Am J Transplant 2006;6(10):2463-9
   PubMedGoogle Scholar
• Yan L, Li B, Zeng Y, et al. Living donor liver transplantation for Budd-Chiari syndrome using cryopreserved vena cava graft in retrohepatic vena cava reconstruction. Liver Transpl 2006;12(6):1017-19
   PubMedGoogle Scholar
• Cruz E, Ascher NL, Roberts JP, et al. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant 2005;19(4):501-6
   PubMedGoogle Scholar
• Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol 2006;44(3):520-8
   PubMedGoogle Scholar
• Halff G, Todo S, Tzakis AG, et al. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990;211(1):43-9
   PubMedGoogle Scholar
• Ringe B, Lang H, Oldhafer KJ, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995;21(5):1337-44
   PubMedGoogle Scholar
• Srinivasan P, Rela M, Prachalias A, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation 2002;73(6):973-7
   PubMedGoogle Scholar
• Melear JM, Goldstein RM, Levy MF, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation 2002;74(8):1090-5
   PubMedGoogle Scholar
• Westbrook RH, Lea NC, Mohamedali AM, et al. Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation. Liver Transpl 2012;18(7):819-27
   PubMedGoogle Scholar
• Bahr MJ, Schubert J, Bleck JS, et al. Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria. Transpl Int 2003;16(12):890-4
   PubMedGoogle Scholar
• Karasu Z, Nart D, Lebe E, et al. Liver transplantation in a patient with Budd-Chiari syndrome secondary to factor V Leiden mutation. Transplant Proc 2003;35(8):3008-10
   PubMedGoogle Scholar
• Ganguli SC, Ramzan NN, McKusick MA, et al. Budd-Chiari syndrome in patients with hematological disease: a therapeutic challenge. Hepatology 1998;27(4):1157-61
   PubMedGoogle Scholar
• Au WY, Fung A, Liu CL, et al. Serial analysis of JAK2 mutation in a patient who developed essential thrombocythemia after orthotopic liver transplantation. Am J Hematol 2006;81(11):880-2
   PubMedGoogle Scholar
• Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39(4):496-501
   PubMedGoogle Scholar
• Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39(2):500-8
   PubMedGoogle Scholar
• Darwish MS, Kim WR, de Groen PC, et al. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl 2007;13(6):867-74
   PubMedGoogle Scholar
• Qi X, Guo W, He C, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int 2013. [Epub ahead of print]
   Google Scholar
• Mohanty D, Shetty S, Ghosh K, et al. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001;34(4 Pt 1):666-70
   PubMedGoogle Scholar
• Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997;40(6):798-800
   PubMedGoogle Scholar
• Bhattacharyya M, Makharia G, Kannan M, et al. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 2004;121(6):844-7
   PubMedGoogle Scholar
• Briere JB. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management. Semin Thromb Hemost 2006;32(3):208-18
   PubMedGoogle Scholar
• Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol 1997;92(5):858-62
   PubMedGoogle Scholar
• Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56(Suppl 1):S25-38
   Google Scholar